Stay updated on ABILITY-1: Beta-IL2 Clinical Trial

Sign up to get notified when there's something new on the ABILITY-1: Beta-IL2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABILITY-1: Beta-IL2 Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now displays an updated interface/version indicator for the ClinicalTrials.gov record history view (moving from v3.5.2 to v3.5.3). This represents a UI/version update rather than a change to the underlying study’s information.
    Difference
    0.1%
    Check dated 2026-04-24T06:39:39.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.5.2 has been added and Revision: v3.5.0 has been removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:50:21.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:57:56.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:17:53.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and the earlier funding-status notice (v3.4.1) was removed.
    Difference
    0.6%
    Check dated 2026-02-11T11:40:51.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added a site-wide funding notice about potential data delays and updated the revision marker to v3.4.1, replacing v3.4.0.
    Difference
    0.6%
    Check dated 2026-02-04T10:20:20.000Z thumbnail image

Stay in the know with updates to ABILITY-1: Beta-IL2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABILITY-1: Beta-IL2 Clinical Trial page.